APRIL MCCAIN: Open Payments
NPI 1043685498 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 26 payments from 5 companies in 2025. Trend: 2023 $229 · 2024 $565 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $190 |
| Paratek Pharmaceuticals, Inc. | 4 | $99 |
| Smith+Nephew, Inc. | 5 | $90 |
| Kerecis Limited | 3 | $47 |
| MIMEDX Group, Inc. | 2 | $37 |
Products named: DALVANCE, NUZYRA, COLLAGENASE SANTYL, Kerecis SurgiClose, EMBLAVEO, TEFLARO.
Industry payments across MS — which companies pay providers there.
